Background. Primary graft dysfunction (PGD) is a syndrome that may occur after lung transplantation. In some cases of severe PGD, conventional therapies like ventilatory support, administration of inhaled nitric oxide (iNO), and surfactant and intravenous prostacyclins are inadequate to achieve adequate gas exchange. The only lifesaving option is to use an extracorporeal membrane oxygenator. The Decapsmart is a new venovenous, low-flow extracorporeal device to removal carbon dioxide (CO2). It does not need a specialized staff. Herein we have presented a case report of a patient who underwent single lung transplantation and experienced respiratory failure. Methods. On November 2007, a 52-year-old woman underwent a single right lung transplantation, and developed severe PGD in the postoperative period. After institution of conventional treatments, including ventilatory and hemodynamic support, iNO, and prostaglandine El, we started treatment with Decapsmart to remove CO2. Hemodynamic and respiratory parameters were assessed at baseline and after 3, 12, 24, and 48 hours. Results. No adverse events occurred. From baseline to 48 hours, pH values increased and partial pressure of CO2 reduced. At the same time ventilatory support was reduced, thereby mitigating barotrauma and risk of overdistension. Conclusion. The use of Decapsmart may be an important aid for patients with severe respiratory acidosis in association with conventional therapy during the perioperative period after lung transplantation.

Extracorporeal Removal CO2 Using a Venovenous, Low-Flow System (Decapsmart) in a Lung Transplanted Patient: A Case Report / F., Ruberto; Pugliese, Francesco; A., D'Alio; S., Perrella; B., D'Auria; S., Ianni; Anile, Marco; Venuta, Federico; Coloni, Giorgio Furio; Pietropaoli, Paolo. - In: TRANSPLANTATION PROCEEDINGS. - ISSN 0041-1345. - 41:4(2009), pp. 1412-1414. ((Intervento presentato al convegno 32nd Congress of the Italian-Transplantation-Society tenutosi a Sorrento, ITALY nel DEC 14-16, 2008 [10.1016/j.transproceed.2009.03.048].

Extracorporeal Removal CO2 Using a Venovenous, Low-Flow System (Decapsmart) in a Lung Transplanted Patient: A Case Report

F. Ruberto;PUGLIESE, Francesco;ANILE, MARCO;VENUTA, Federico;COLONI, Giorgio Furio;PIETROPAOLI, Paolo
2009

Abstract

Background. Primary graft dysfunction (PGD) is a syndrome that may occur after lung transplantation. In some cases of severe PGD, conventional therapies like ventilatory support, administration of inhaled nitric oxide (iNO), and surfactant and intravenous prostacyclins are inadequate to achieve adequate gas exchange. The only lifesaving option is to use an extracorporeal membrane oxygenator. The Decapsmart is a new venovenous, low-flow extracorporeal device to removal carbon dioxide (CO2). It does not need a specialized staff. Herein we have presented a case report of a patient who underwent single lung transplantation and experienced respiratory failure. Methods. On November 2007, a 52-year-old woman underwent a single right lung transplantation, and developed severe PGD in the postoperative period. After institution of conventional treatments, including ventilatory and hemodynamic support, iNO, and prostaglandine El, we started treatment with Decapsmart to remove CO2. Hemodynamic and respiratory parameters were assessed at baseline and after 3, 12, 24, and 48 hours. Results. No adverse events occurred. From baseline to 48 hours, pH values increased and partial pressure of CO2 reduced. At the same time ventilatory support was reduced, thereby mitigating barotrauma and risk of overdistension. Conclusion. The use of Decapsmart may be an important aid for patients with severe respiratory acidosis in association with conventional therapy during the perioperative period after lung transplantation.
01 Pubblicazione su rivista::01a Articolo in rivista
Extracorporeal Removal CO2 Using a Venovenous, Low-Flow System (Decapsmart) in a Lung Transplanted Patient: A Case Report / F., Ruberto; Pugliese, Francesco; A., D'Alio; S., Perrella; B., D'Auria; S., Ianni; Anile, Marco; Venuta, Federico; Coloni, Giorgio Furio; Pietropaoli, Paolo. - In: TRANSPLANTATION PROCEEDINGS. - ISSN 0041-1345. - 41:4(2009), pp. 1412-1414. ((Intervento presentato al convegno 32nd Congress of the Italian-Transplantation-Society tenutosi a Sorrento, ITALY nel DEC 14-16, 2008 [10.1016/j.transproceed.2009.03.048].
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/227009
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 23
social impact